- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 289.01M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 286.51M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $133.44M |
| Capex | Q1 2026 · Mar 31, 2025 | $258.43M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $238.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $206.76M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.34B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.88B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $5.63B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.77B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.77B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.36B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $35.7B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $37.2B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.55B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.13B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $41.38B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $43.02B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.51 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.71 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.51 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.71 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $639.03M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $597.85M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $16M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $18M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$146.89M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$202.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $392.85M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$88.13M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.67B |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.87B |